Metabolic phenotype of male obesity-related secondary hypogonadism pre-replacement and post-replacement therapy with intra-muscular testosterone undecanoate therapy.

Georgios K DimitriadishHarpal S RandevaSaboor AftabAsad AliJohn G HattersleySarojini PandeyDimitris K GrammatopoulosGeorgios ValsamakisGeorgios MastorakosT Hugh JonesThomas M Barber

Published in: Endocrine (2018)

In men with obesity-related SH (including a subgroup with T2D), TU IM therapy improved glycaemic control, beta cell function, and body composition.

Keyphrases

replacement therapy
body composition
resistance training
type diabetes
smoking cessation
insulin resistance
metabolic syndrome
weight loss
weight gain
bone mineral density
high fat diet induced
clinical trial
body mass index
skeletal muscle
middle aged
bone marrow
open label
drug induced
study protocol